Inventor
Mark Throsby
Inventor
Utrecht, NL
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes15%
C12NMicroorganisms or enzymes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
A01KAnimal husbandry3%
C40BCombinatorial chemistry3%
Y02ATechnologies for adaptation to climate change3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
PatentTitleYear
11,091,550Bispecific antibody202110,966,411Antibody producing non-human mammals202110,844,127Antibodies that bind EGFR and ErbB3202010,647,781Generation of binding molecules202010,605,808Antibody producing non-human animals202010,005,831Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof20189,944,695Antibody producing non-human mammals20189,908,946'Generation of binding molecules'20189,765,133'Antibody producing non-human mammals'20179,611,317'Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof'20179,428,572'Human binding molecules having killing activity against enterococci'20169,145,588'Generation of binding molecules'20159,109,017'Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof'20159,011,848'Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof'20158,911,738'Host cell specific binding molecules capable of neutralizing viruses and uses thereof'20148,691,223'Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof'20148,642,513'Method for preparing immunoglobulin libraries'20148,628,776'Human binding molecules against enterococci and Staphylococcus'20148,470,327'Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof'20138,460,666'Human binding molecules having killing activity against staphylococci and uses thereof'20138,241,631'Human binding molecules having killing activity against enterococci and uses thereof'20128,211,431'Human binding molecules having killing activity against staphylococci and uses thereof'20128,192,927'Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof'20128,052,974'Host cell specific binding molecules capable of neutralizing viruses and uses thereof'20117,968,092'Human binding molecule against CD1a'20117,960,518'Human binding molecules having killing activity against enterococci and uses thereof'20117,537,764'Binding molecules capable of neutralizing west nile virus and uses thereof'20097,244,430'Binding molecules capable of neutralizing West Nile virus and uses thereof'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2018Patents assigned to CRUCELL HOLLAND BV (19)· patent assignee history
2007–2021Based in Utrecht, NL· patent location history
2012–2021Patents assigned to THROSBY MARK (11)· patent assignee history
2012–2015Patents assigned to DE KRUIF CORNELIS ADRIAAN (8)· patent assignee history
2015–2018Patents assigned to MERUS B V (4)· patent assignee history
2017–2021Patents assigned to MERUS NV (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CRUCELL HOLLAND BV | 19 | 2007–2018 |
| THROSBY MARKself | 11 | 2012–2021 |
| DE KRUIF CORNELIS ADRIAAN | 8 | 2012–2015 |
| MERUS NV | 7 | 2017–2021 |
| MERUS B V | 4 | 2015–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Utrecht, NL | 28 | 2007–2021 |